Qube Research & Technologies (QRT)
ORIC icon

Qube Research & Technologies (QRT)’s Oric Pharmaceuticals ORIC Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.9M Sell
859,491
-345,938
-29% -$3.93M 0.02% 1226
2025
Q4 		$9.86M Buy
+1,205,429
New +$13.9M 0.01% 1354
2024
Q3 		– Sell
-81,227
Closed -$574K – 3904
2024
Q2 		$574K Buy
81,227
+28,184
+53% +$252K ﹤0.01% 2100
2024
Q1 		$729K Buy
+53,043
New +$630K ﹤0.01% 2331
2023
Q2 		– Sell
-67,466
Closed -$385K – 2833
2023
Q1 		$385K Buy
67,466
+27,778
+70% +$145K ﹤0.01% 1656
2022
Q4 		$234K Buy
39,688
+14,028
+55% +$47.4K ﹤0.01% 1745
2022
Q3 		$82K Sell
25,660
-5,393
-17% -$21.6K ﹤0.01% 2028
2022
Q2 		$139K Buy
+31,053
New +$124K ﹤0.01% 1827
2021
Q3 		– Sell
-22,512
Closed -$398K – 2626
2021
Q2 		$398K Buy
+22,512
New +$493K 0.01% 1401

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $22.1B AUM 51.63% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return